The largest database of trusted experimental protocols

3 protocols using nox2ds tat

1

Evaluating Endothelial Cell Responses to Cortisol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human umbilical vein endothelial cells (HUVECs) (Lonza, Basel, Switzerland, Cat. N. CC-C2517A) were cultured in complete EGM-2 medium (Lonza Cat. No. CC-3162) and 10% FBS and were plated at a density of 2500 cells per cm2. HUVECs were seeded and grown overnight to a sub-confluence level.
Before activation, cells were pre-incubated (20 min at 37 °C) with NOX2ds-tat (10 μM; Anaspec, Fremont, CA, USA), a NOX2 inhibitor. After incubation, cells were treated with cortisol (175 or 256 ng/mL) for 3 h.
Conditioned media were collected to quantify soluble biomarkers, such as H2O2, sNOX2dp, endothelin-1 and NO, and pellets were analyzed with Western blot in order to verify p-eNOS expression. The experiments were conducted on five different batches of HUVECs.
+ Open protocol
+ Expand
2

Murine Macrophage Activation by Biglycan

Check if the same lab product or an alternative is used in the 5 most similar protocols
Murine thioglycolate-elicited macrophages were isolated from peritoneal lavage and grown in RPMI 1640 (Life Technologies, Germany) supplemented with 1% penicillin and streptomycin and 2% fetal bovine serum (Biochrom, Germany). Cells were stimulated with 4 μg/ml (80 nM) human biglycan in serum-free medium for indicated time periods. Phorbol 12-myristate 13-acetate (PMA) (100 nM; Sigma, Germany) served as positive control for p47phox translocation studies. For ROS inhibition diphenyleneiodonium chloride (DPI, 0.5 μM; Sigma, Germany), VAS2870 (5 μM; Sigma, Germany), ML-171 (10 nM; Merck, Germany), Nox2ds-tat (40 μM; AnaSpec, USA) and GKT137831 (200 μM) were applied to the macrophages 1 h prior to stimulation with biglycan. For immunofluorescence studies Akt inhibitor 124008 (1 μM; Calbiochem, Germany), p38 MAPK inhibitor SB203580 (10 μM; Calbiochem, Germany), MEK1/2 inhibitor UO126 (10 μM; Cell Signaling, Germany), PI3K inhibitor LY294002 (10 μM; Cell Signaling, Germany), Rac1 inhibitor (50 μM; Calbiochem, Germany), PKC inhibitor GO6976 (20 nM; Sigma, Germany) and MyD88 inhibitor peptide NBP2–29328 (50 μM; Novus Biologicals, Germany) were applied 1 h prior to stimulation with biglycan. For HSP70 inhibition phenylsulfonamide (PES, pifithrin-μ) (200 μM; Sigma, Germany) was applied to the cells in addition to biglycan.
+ Open protocol
+ Expand
3

Modulation of Skeletal Muscle Myoblasts

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Human skeletal muscle myoblasts cell line (HSMM, Lonza, Basel, Switzerland) was cultured in SkBMTM-2 Basal Medium and SkGMTM-2 SingleQuotsTM supplements, 2 mM glutamine, and 1% antibiotics (all Gibco) for expansion and maintenance of the undifferentiating state. When cultures reached 80% confluence, myogenic differentiation was induced by replacing the expansion media with DMEM/0.2% FBS. Afterward, cells were pre-treated for 2 h either with vehicle (Phosphate Buffered Saline, PBS) or NOX2ds-tat (10 μM in PBS; Anaspec, Fremont, CA, USA), the most specific inhibitor of interactions between NOX2 and p47phox [28 (link)]. Cells were then stimulated with 10% plasma obtained from 3 different amateurs and 3 different elites’ athletes for 24 h.
Experiments were also conducted by treating cells either with vehicle (ddH2O) or cocoa-derived polyphenols (1 μM in ddH2O) for 1 h before stimulation with 10% plasma obtained from 3 amateurs and 3 elites’ athletes for 24 h. The cocoa-derived polyphenols concentration was chosen as the lowest non-toxic concentration to obtain the inhibition. The experiments were conducted on three different batches of HSMM.
Conditioned media were harvested and tested for the quantification of soluble NOX2 and H2O2 as described, and pellets were analysed in western blot to verify muscle damage with α-actin expression.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!